Elimination of palmitoylation sites in the human dopamine D 1 receptor does not affect receptor-G protein interaction

By Jin H.   Zastawny R.   George S.R.   O'Dowd B.F.  

European Journal of Pharmacology, Vol. 324, Iss. 1, 1997-04 ,pp. : 109-116

Elsevier

Access to resources Recommend Favorite

Dopamine D1 receptor agonists as antiparkinson drugs

By Mailman R.B.   Nichols D.E.  

Trends in Pharmacological Sciences, Vol. 19, Iss. 7, 1998-07 ,pp. : 255-256

Elsevier

Access to resources Recommend Favorite

Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines

By Neumeyer J.L.   Kula N.S.   Bergman J.   Baldessarini R.J.  

European Journal of Pharmacology, Vol. 474, Iss. 2, 2003-08 ,pp. : 137-140

Elsevier

Access to resources Recommend Favorite

Modification of dopamine D 1 receptor knockout phenotype in mice lacking both dopamine D 1 and D 3 receptors

By Karasinska J.M.   George S.R.   El-Ghundi M.   Fletcher P.J.   O'Dowd B.F.  

European Journal of Pharmacology, Vol. 399, Iss. 2, 2000-07 ,pp. : 171-181

Elsevier

Access to resources Recommend Favorite

Protein Cysteine Modifications: (1) Medicinal Chemistry for Proteomics

By  

Current Medicinal Chemistry, Vol. 16, Iss. 33, 2009-11 ,pp. : 4419-4444

Bentham Science Publishers

Access to resources Recommend Favorite